Tanta University: Fatty Liver trials
The registry lists 12 Fatty Liver studies with Tanta University as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 6Phase 3 3Phase 4 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Erdosteine in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingNCT07242222Phase 1/2
- Cilostazol in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingNCT07238985Phase 1/2
- Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver DiseaseRecruitingNCT06739330
- the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.RecruitingNCT05942547Phase 3
- Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNot yet recruitingNCT05731596Phase 3
- Evaluating the Efficacy and Safety of Roflumilast in Patients with NASHCompletedNCT06677788Phase 2
- MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian PatientsCompletedNCT06492369
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisStatus unknownNCT05605158Phase 3
- High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05578404Phase 2
- Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients with HyperuricemiaActive, not recruitingNCT05574036Phase 2
- Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisActive, not recruitingNCT05573204Phase 2
- Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)CompletedNCT04537780Phase 4